MANH vs NICE Stock Comparison
MANH currently leads NICE in this stock comparison, with AIQ scores of 71 vs 68. The clearest difference is momentum, while NICE has the stronger value profile.
What is the main difference between MANH and NICE?
MANH leads the current stock comparison as Manhattan Associates, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Manhattan Associates, Inc. vs NICE Ltd.
MANH leads
MANH leads by 3 AIQ points, primarily on Momentum, and the lead has widened from 0 points over 30 sessions. Wall Street currently favors NICE on target upside.
Fragile: 2 of 6 evidence groups support MANH, its lead is widening, and its current signal state is conflicted.
Manhattan Associates, Inc.
NICE Ltd.
The Algovestiq AIQ Score currently favors MANH over NICE, 71 versus 68 as of Nov 15, 2026. MANH's advantage is driven primarily by stronger momentum, while NICE holds the stronger value profile. MANH also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors NICE. 2 of 6 covered evidence groups favor MANH today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. MANH lead: Strengthening — the AIQ differential moved from 0 to 3 points over 30 sessions.
Compare Manhattan Associates, Inc. and NICE Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare MANH and NICE against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value39 vs 84NICE +45
- Momentum94 vs 64MANH +30
- Quality66 vs 64Even
- Risk Resilience69 vs 67Even
2 of 6 evidence groups favor MANH. MANH’s edge is concentrated in momentum; NICE keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
No factor moved materially.
New signals
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-11.2%)
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
Largest factor move: Value -2
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-14.4%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
MANH's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — MANH and NICE both carry a full feed there.
The central trade-off
MANH (Manhattan Associates, Inc.): the stronger current systematic profile, led by momentum.
NICE (NICE Ltd.): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 40.3% against 26.1%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
MANHMANH on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
MANHMANH on combined revenue and EPS growth.
Value
NICENICE on the peer-relative Value factor, by 45 points.
Momentum
MANHMANH on the Momentum factor, by 30 points.
Lower downside
MANHMANH carries the lower 1-month annualized volatility.
Analyst upside
NICENICE on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors MANH, analyst targets favor NICE. That disagreement is the most useful thing on this page.
| Measure | MANH | NICE | Note |
|---|---|---|---|
| Implied upside to target | +8.5% | +57.2% | NICE has more room |
| Target dispersion | +19.7% | +8.6% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 14 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 6 covered evidence groups favor MANH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 71 vs 68 |
| Fundamentals | MANHon balance | revenue growth 2.8% vs -1.4%; EPS growth 23.5% vs 12.5%; TTM ROE 30.6% vs 2.5%; gross margin 54.9% vs 64%; operating margin 24.1% vs 17% — MANH takes 4 of 5 decided legs, not all of them |
| Valuation | NICE | Value 39 vs 84 |
| Technicals | MANH | Price vs 50-day 14.7% vs -12.2%; vs 200-day 50.6% vs -8% |
| Risk Resilience | Even | Risk Resilience 69 vs 67 |
| Analyst expectations | NICE | Target upside 8.5% vs 57.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of MANH and NICE and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
- Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MANH.
How the comparison changed
120 daily snapshots · May 27 – Nov 13MANH lead: Strengthening — the AIQ differential moved from 0 to 3 points over 30 sessions.
- Today
- MANH +3
- 71 vs 68
- 7 sessions ago
- NICE +1
- 71 vs 72
- 30 sessions ago
- Level
- 69 vs 69
- 90 sessions ago
- MANH +4
- 65 vs 61
The lead changed hands 4 times in this window, most recently on Nov 4 when NICE moved ahead of MANH.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
5 bullish / 3 bearish, conflicted
Only MANH
- 52-Week High Proximity — bullish, risk_regime, long horizon (1.9%)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-11.2%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.35x)
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
3 bullish / 1 bearish / 2 neutral, conflicted
Only NICE
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.60%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-14.4%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
Both carry 1 more signal that do not separate them: Golden Cross Active.
MANH leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.3%, AIQ 0 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +2.04%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1NICE closes the Momentum gap — currently 30 points behind, the largest single contributor to MANH's edge.
- 2NICE's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
- 3MANH's conflicting signal state resolves bearish — it currently carries 5 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
MANH leads on balance| Metric | MANH | NICE |
|---|---|---|
| Revenue growth (YoY) | 2.8% | -1.4% |
| EPS growth (YoY) | 23.5% | 12.5% |
| Gross margin | 54.9% | 64% |
| Operating margin | 24.1% | 17% |
| Return on equity (TTM) | 30.6% | 2.5% |
| Debt to equity | 0.26 | 0.02 |
Performance
MANH leads 6 of 6 windows| Metric | MANH | NICE |
|---|---|---|
| 1 week (5 sessions) | 1.7% | -0.1% |
| 1 month (20 sessions) | 15.7% | -14.4% |
| 3 months (63 sessions) | 30.9% | -1.9% |
| 6 months (126 sessions) | 95.8% | 7% |
| Year to date | 48.4% | -15% |
| 1 year (252 sessions) | 46.7% | -22.7% |
Technicals
MANH has the stronger structure| Metric | MANH | NICE |
|---|---|---|
| RSI (14) | 67.7 | 32.7 |
| ADX (14) | 38.8 | 32 |
| Price vs 50-day | 14.7% | -12.2% |
| Price vs 200-day | 50.6% | -8% |
| Volatility (1M, annualized) | 26.1% | 40.3% |
Risk
Split| Metric | MANH | NICE |
|---|---|---|
| Beta | 0.24 | 0.26 |
| Sharpe ratio | 0.94 | -0.38 |
| Sortino ratio | 1.47 | -0.52 |
| Max drawdown | -32.7% | -37.7% |
| Current drawdown | -1.3% | -28% |
| Annualized volatility | 46.9% | 54.1% |
| Value at risk (95%) | -4.1% | -4.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, MANH or NICE?
On the Algovestiq AIQ Score, MANH is the stronger of the two as of Nov 15, 2026, scoring 71 against NICE's 68. The edge comes from momentum. NICE is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is MANH or NICE the better buy right now?
MANH carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.
Why does the AIQ Score favor MANH over NICE?
The composite weights Quality, Value, Momentum and Risk Resilience. NICE leads Value by 45 points; MANH leads Momentum by 30 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, MANH or NICE?
Analyst price targets imply +8.5% upside for MANH and +57.2% for NICE, so the Street currently favors NICE. That points the opposite way to the AIQ Score, which favors MANH. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, MANH or NICE?
NICE is the better-valued of the two on the peer-relative Value factor. NICE on the peer-relative Value factor, by 45 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, MANH or NICE?
MANH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, MANH or NICE?
MANH on the Momentum factor, by 30 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, MANH or NICE?
MANH is the more resilient of the two, so the other name carries the higher downside risk. MANH carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is MANH more profitable than NICE?
The profitability evidence is mixed: gross margin 54.9% vs 64%; operating margin 24.1% vs 17%; ttm roe 30.6% vs 2.5%. MANH leads on two measures and NICE on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is MANH's lead over NICE getting stronger or weaker?
MANH lead: Strengthening — the AIQ differential moved from 0 to 3 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 4 times in that window, most recently on 2026-11-04, when NICE moved ahead of MANH.
What would change the MANH vs NICE verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: NICE closes the Momentum gap — currently 30 points behind, the largest single contributor to MANH's edge; NICE's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; MANH's conflicting signal state resolves bearish — it currently carries 5 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about MANH and NICE?
MANH: 5 bullish / 3 bearish, conflicted. NICE: 3 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on MANH is Golden Cross Active (bullish, long horizon). On NICE it is Golden Cross Active (bullish, long horizon).
Compare MANH and NICE with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.